Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 100 /hr
Hire Dr. Kirti K.
India
USD 100 /hr
Scientific/Medical writer with experience in cancer biology and immunology
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Technical Writing
Work Experience
PhD Researcher
Bose Institute
September 2010 - October 2019
PhD Researcher
BOSE INSTITUTE
September 2010 - October 2019
Education
M.Sc.
Dr.B.R.Ambedkar Centre for Biomedical Research
July 2008 - April 2010
B.Sc.
Birla Institute of Medical Research
April 2005 - April 2008
Certifications
Publications
JOURNAL ARTICLE
Kirti Kajal and Sayantan Bose and Abir K. Panda and Dwaipayan Chakraborty and Sreeparna Chakraborty and Subhadip Pati and Tania Sarkar and Subhanki Dhar and Dia Roy and Shilpi Saha and Gaurisankar Sa(2021). Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients . Cancer Immunology, Immunotherapy. Springer Science and Business Media {LLC}
(2019). Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis. Scientific Reports.
(2018). Providence of the CD25(+) KIR(+) CD127(-) FOXP3(-) CD8(+) T-cell subset determines the dynamics of tumor immune surveillance. Immunology & Cell Biology.
(2017). Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8+ Treg cells. Scientific Reports.
(2016). Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB-IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells. Cancer Research.
(2015). Intratumoral Immune Landscape: Immunogenicity to Tolerogenicity. Austin Journal of Clinical Immunology.
(2015). Sulphur alters NFκBp300 cross-talk in favour of p53-p300 to induce apoptosis in non-small cell lung carcinoma. International Journal of Oncology.
(2014). Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin. Translational Research.
(2014). MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu. Immunology.
BOOK CHAPTER
(2017). Role of proteases in tumor immune evasion. In: Pathophysiological aspects of proteases. Pathophysiological Aspects of Proteases.